Sponsor pipeline

Scripps Translational Science Institute clinical trial pipeline

Get alerts when Scripps Translational Science Institute's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-29 NCT07847918 A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders Phase 2 Recruiting

Active trials by phase

Phase 2
2
Not charted: 17 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 12

Heart Disease (5) · Coronary Artery Disease (3) · Alzheimer's Disease (1) · Atrial Fibrillation (1) · Dementia (1) · Diabetes (1) · Epilepsy (1) · Obesity (1) · Ovarian Cancer (1) · Parkinson's Disease (1)

Get alerts when Scripps Translational Science Institute's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free